CLOSE

Specials

I agree We use cookies on this website to enhance your user experience. By clicking any link on this page you are giving your consent for us to set cookies. More info

Skip to: Curated Story Group 1
lifesciencesreview
US
EUROPE
APAC
CANADA
  • US
    • US
    • EUROPE
    • APAC
    • CANADA
    • LATAM
  • Home
  • Contributors
  • News
  • Conferences
  • Newsletter
  • Whitepapers
  • Magazine
×
#

Life Science Review Weekly Brief

Be first to read the latest tech news, Industry Leader's Insights, and CIO interviews of medium and large enterprises exclusively from Life Science Review

Subscribe

loading

Thank you for Subscribing to Life Science Review Weekly Brief

  • Home
  • News

Recommended picks

Hiring the Right CRO to Improve Clinical Trial Outcomes

Hiring the Right CRO to Improve...

 Altasciences Receives Accreditation From College Of American Pathologists

Altasciences Receives Accreditation...

Life Science Marketing: Content Distribution for Businesses

Life Science Marketing: Content...

Protypia, Inc.'S Acquisition By Inotiv, Inc. Broadens The Company's Protein/Peptide Bioanalytical Capabilities

Protypia, Inc.'S Acquisition By...

Making the Most of Contract Research Organization Relationships

Making the Most of Contract Research...

How Cloudbased Lims Helps Cros

How Cloudbased Lims Helps Cros

MMS Holdings Announces New Pro-Bono Support Program

MMS Holdings Announces New Pro-Bono...

Inotiv Secures MilliporeSigmas BioReliance Genetic Toxicology Assets

Inotiv Secures MilliporeSigmas...

Hiring the Right CRO to Improve Clinical Trial Outcomes

Hiring the Right CRO to Improve...

 Altasciences Receives Accreditation From College Of American Pathologists

Altasciences Receives Accreditation...

Life Science Marketing: Content Distribution for Businesses

Life Science Marketing: Content...

Protypia, Inc.'S Acquisition By Inotiv, Inc. Broadens The Company's Protein/Peptide Bioanalytical Capabilities

Protypia, Inc.'S Acquisition By...

Making the Most of Contract Research Organization Relationships

Making the Most of Contract Research...

How Cloudbased Lims Helps Cros

How Cloudbased Lims Helps Cros

MMS Holdings Announces New Pro-Bono Support Program

MMS Holdings Announces New Pro-Bono...

Inotiv Secures MilliporeSigmas BioReliance Genetic Toxicology Assets

Inotiv Secures MilliporeSigmas...

PPD and Science 37 Announce an Innovative Collaboration

Life Sciences Review Life Sciences Review | Thursday, May 20, 2021
Tweet

PPD Digital would be able to use Science 37’s configurable, SaaS-based DCT technology platform to design and implement Remote e-consent, eCOA, eSource, and fully decentralized trials result of their successful two-year collaboration under Science 37’s CRO Certified program.


FREMONT, CA: PPD, a leading global contract research organization (CRO), and Science 37, the creator of the Decentralized Clinical Trial Operating System (DCT OS), announced a groundbreaking partnership under which PPD would be fully equipped to design, develop, test, enforce, and conduct digital trials using Science 37’s DCT SaaS-based technology framework.


PPD Digital would be able to use Science 37’s configurable, SaaS-based DCT technology platform to design and implement Remote e-consent, eCOA, eSource, and fully decentralized trials result of their successful two-year collaboration under Science 37’s CRO Certified program. This will improve the company’s efficiency and effectiveness in delivering studies for a variety of clients.


“Our success with Science 37 has positioned us well to implement and incorporate its technology platform into our clinical trial services model, which is on course with our efforts to maintain a leadership position in the global transition toward decentralized clinical trials,” said Niklas Morton, senior vice president, PPD Digital. “Our overall DCT strategy is to offer customers more trial delivery options, particularly in a stepwise fashion where the customer can experience both traditional and digital approaches to sites and patients in the same study. Through our evolving collaboration, we will be able to use the Science 37 platform to provide our customers with a best-in-class service and delivery model.”


PPD Digital offers decentralized trial solutions that maximize patient access and boost the patient experience, resulting in time savings and improved data quality that can help shorten implementation timelines.


 


These programs dramatically reduce patient burden, primarily by fewer site visits, while providing clients with a more significant regional scope through reduced dependency on sites, more timely data access, increased quality and accuracy, and improved patient involvement.


“Science 37 intends to be the operating system to enable all decentralized clinical trials,” said Steve Geffon, chief commercial officer, Science 37. “By enabling PPD Digital to utilize our innovative platform, were able to extend our reach and enable decentralization on more trials than ever before. Our new SaaS-based technology makes it easy to deploy Remote eConsent, eCOA, eSource and fully decentralized trials, even when it is not part of the complete Science 37 DCT Operating System, which includes patient communities, telemedicine investigators, mobile nurses, remote coordinators and connected devices.”


Information Services Group (ISG), a leading global technology research and advisory company, honored PPD earlier this month for industry leadership in digital and decentralized clinical trial solutions. PPD’s clinical growth and patient experience solutions were named an ISG Provider Lens Leader by ISG for the CRO’s digital transformation services.


PPD led Science 37’s series D funding round in 2019 and collaborated to provide virtual sites to supplement conventional brick-and-mortar sites. This early investment has facilitated PPD to solution protocol development and protocol adjustment processes to enable DCT design flexibility; optimize the study startup process and workflow to guarantee faster site activation timelines; utilize the PPD business Accelerated Enrollment Solutions to maximize patient recruitment potential, and incorporate data acquisition at sites with PPD’s data management and Preclarus platform to warrant real data access across all sites.


Weekly Brief

loading
Top 10 Preeminent Cros – 2022
> <
  • Regulatory Services 2023

    Top Vendors

    Current Issue
  • Clinical Lab Equipment 2023

    Top Vendors

    Current Issue
  • Regulatory Services 2023

    Top Vendors

    Current Issue
  • Clinical Lab Equipment 2023

    Top Vendors

    Current Issue

Read Also

Prophesying DNA Sequencing for 2023

Crucial Workflows of Next-Generation Sequencing

An Overview of Next-Generation Sequencing

The Role of AI in Accurate Medical Writing

Patrik Renblad to Join Cantargia as Chief Financial Officer

Overview of the Life Sciences BPO Market

Dr. Zamaneh Mikhak Joins TFF Pharmaceutical as the New Chief Medical Officer

The Significance of AI in Medical Writing

Loading...

Copyright © 2023 Life Sciences Review . All rights reserved. |  Subscribe |  About Us follow on linkedin

This content is copyright protected

However, if you would like to share the information in this article, you may use the link below:

https://www.lifesciencesreview.com/news/ppd-and-science-37-announce-an-innovative-collaboration--nwid-371.html